Randomized, Open-label, Three-arm, Parallel, Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole Versus Letrozole or Vinorelbine Alone in Post-menopausal Women With Hormone Receptor-positive HER2-negative Early Breast Cancer
Phase of Trial: Phase 0
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Vinorelbine (Primary) ; Letrozole
- Indications Early breast cancer
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms VENTANA
- 12 Sep 2017 Trial design presented at the 42nd European Society for Medical Oncology Congress.
- 15 Feb 2017 Status changed from not yet recruiting to recruiting.
- 22 Jun 2016 New trial record